Hemangioblastoma of the central nervous system
Conditions
Interventions
Control group:Blank
Sponsors
Department of Neurosurgery of Huashan Hospital Affiliated to Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. MRI diagnosis has one or more HBs of the head or spinal cord, signed informed consent, voluntary participation in the study; 2. the diameter of the tumor located in the skull is less than 3cm, and the diameter of the tumor located in the spinal cord is less than 2cm 3. KPS score >60 score; 4. Aged 18 to 70 years old.
Exclusion criteria
Exclusion criteria: 1. selected as drug users who used VEGF inhibitors before; 2. pairs of hypersensitive patients with sodium hydrochloric acid; 3. patients with allergic asthma and allergic rhinitis; 4. sinus bradycardia, severe atrioventricular block, cardiogenic shock, hypotension; 5. the diameter of tumor is greater than or equal to 4cm, which has the risk of brain hernia; 6. for other clinical trials in the last 3 months; 7. the researchers considered it inappropriate to participate in this clinical trial; 8. pregnant women, lactating women or recent fertility planners.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tumor diameter; | — |
Countries
China
Contacts
Public ContactLiangfu Zhou
Huashan Hospital Affiliated to Fudan University
Outcome results
None listed